Rethinking the author name ambiguity problem and beyond: The case of the Chinese context.
Account Res
; : 1-24, 2024 May 05.
Article
en En
| MEDLINE
| ID: mdl-38704656
ABSTRACT
The perennial problem of author name ambiguity has attracted increasing attention in the academic community. Drawing on the literature, this article first highlights the pervasiveness of the problem and discusses its adverse consequences. It then analyzes the behavioral causes of the problem in the Chinese context and attributes them to personal, cultural, and institutional factors. Informed by this analysis and recognizing ORCID as a promising solution, we propose an ORCID-based "Prevention plus Cure" campaign against author name ambiguity. The prevention objective relies on researchers' consistent use of ORCID, while the cure objective involves retrospectively integrating ORCIDs into backfile publications. We also outline the responsibilities of various stakeholders to ensure the success of the campaign. Furthermore, we argue that universal adoption of ORCID can help curb authorship-related misconduct, discern predatory journals and publishers, and track researchers' undesirable records of academic publishing. We then analyze the current status of ORCID adoption in China, identify potential challenges, propose tentative solutions to address them, and highlight ORCID as a tool that can be utilized to empower China's combat against research misconduct. In conclusion, we emphasize the importance of conducting empirical research to inform more effective promotion of ORCID adoption in China.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Account Res
Asunto de la revista:
ETICA
Año:
2024
Tipo del documento:
Article
País de afiliación:
China
Pais de publicación:
Estados Unidos